Histone Modulation by Triptolide Contributes to Cell Death in Pancreatic Ductal Adenocarcinoma

被引：0
|
作者：
Kurtom, S. [1 ]
Giri, B. [1 ]
Ferrantella, A. [1 ]
Sethi, V. [1 ]
Garg, B. [1 ]
Banerjee, S. [1 ]
Saluja, A. [1 ]
Dudeja, V. [1 ]
机构：
[1] Univ Miami, Miami, FL USA
来源：
ANNALS OF SURGICAL ONCOLOGY | 2018年 / 25卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
PT123
引用
收藏
页码：S123 / S123
页数：1
相关论文
共 50 条
  • [1] Targeting histone deacetylases in pancreatic ductal adenocarcinoma
    Schneider, Guenter
    Kraemer, Oliver H.
    Fritsche, Petra
    Schueler, Susanne
    Schmid, Roland M.
    Saur, Dieter
    JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2010, 14 (06) : 1255 - 1263
  • [2] The Role of Histone Deacetylases in Pancreatic Ductal Adenocarcinoma
    Mousavi, F.
    Pin, C. L.
    PANCREAS, 2021, 50 (07) : 1084 - 1084
  • [3] Mechanisms of Cancer Cell Death: Therapeutic Implications for Pancreatic Ductal Adenocarcinoma
    Pook, Hannah
    Pauklin, Siim
    CANCERS, 2021, 13 (19)
  • [4] NFAT family contributes to early recurrence in pancreatic ductal adenocarcinoma
    Hiroshima, Yukihiko
    Kasajima, Rika
    Ohtsu, Takashi
    Miyagi, Yohei
    CANCER SCIENCE, 2021, 112 : 495 - 495
  • [5] Global histone modifications as markers of pancreatic ductal adenocarcinoma prognosis
    Lu, Y.
    Kim, L.
    Frederick, B.
    Zhang, M.
    Liao, J.
    Talamonti, M.
    Bentrem, D.
    Rao, S. M.
    Yang, G. Y.
    LABORATORY INVESTIGATION, 2008, 88 : 310A - 310A
  • [6] Oncogenic Kras induces histone acetylation in pancreatic ductal adenocarcinoma
    Carrer, Alessandro
    Lee, Joyce V.
    Shah, Supriya
    Snyder, Nathaniel W.
    Jackson, Ellen
    Aiello, Nicole M.
    Garcia, Benjamin A.
    Chodosh, Lewis A.
    Stanger, Ben Z.
    Blair, Ian A.
    Wellen, Kathryn E.
    CANCER RESEARCH, 2015, 75
  • [7] Global histone modifications as markers of pancreatic ductal adenocarcinoma prognosis
    Lu, Y.
    Kim, L.
    Frederick, B.
    Zhang, M.
    Talamonti, M.
    Bentrem, D.
    Rao, S. M.
    Yang, G. Y.
    MODERN PATHOLOGY, 2008, 21 : 310A - 310A
  • [8] Epigenetic modulation enhances immunotherapy for pancreatic ductal adenocarcinoma
    Li, Yan
    Hong, Young K.
    Wang, Xingtong
    Pandit, Harshul
    Zheng, Qianqian
    Yu, Youxi
    Shi, Xiaoju
    Chen, Yujia
    Tan, Min
    Pulliam, Zachary
    Bhutiani, Neal
    Lin, Andrew
    Badach, Jeremy
    Zhang, Ping
    Martin, Robert C. G.
    CLINICAL & TRANSLATIONAL IMMUNOLOGY, 2022, 11 (12)
  • [9] Downregulation of ZNF395 contributes to enhanced cell proliferation and progression in pancreatic ductal adenocarcinoma
    Kurogi, Shusaku
    Hijiya, Naoki
    Tsukamoto, Yoshiyuki
    Nakada, Chisato
    Inomata, Masafumi
    Kobayashi, Takashi
    Moriyama, Masatsugu
    CANCER SCIENCE, 2021, 112 : 809 - 809
  • [10] ADAM9 contributes to vascular invasion in pancreatic ductal adenocarcinoma
    Oria, Victor O.
    Lopatta, Paul
    Schmitz, Tatjana
    Preca, Bogdan-Tiberius
    Nystroem, Alexander
    Conrad, Catharina
    Bartsch, Joerg W.
    Kulemann, Birte
    Hoeppner, Jens
    Maurer, Jochen
    Bronsert, Peter
    Schilling, Oliver
    MOLECULAR ONCOLOGY, 2019, 13 (02) : 456 - 479
12345